BA
ALXN
Bridgewater Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,302
| Closed | -$790K | – | 820 |
|
|
2021
Q2 | $790K | Sell |
4,302
-1,909
| -31% | -$351K | 0.01% | 609 |
|
|
2021
Q1 | $950K | Sell |
6,211
-3,289
| -35% | -$503K | 0.01% | 324 |
|
|
2020
Q4 | $1.48M | Buy |
+9,500
| New | +$1.48M | 0.01% | 339 |
|
|
2019
Q4 | – | Sell |
-475,487
| Closed | -$46.6M | – | 585 |
|
|
2019
Q3 | $46.6M | Buy |
475,487
+445,246
| +1,472% | +$43.6M | 0.41% | 27 |
|
|
2019
Q2 | $3.96M | Buy |
+30,241
| New | +$3.96M | 0.03% | 161 |
|
|
2019
Q1 | – | Sell |
-277,885
| Closed | -$27.1M | – | 537 |
|
|
2018
Q4 | $27.1M | Buy |
+277,885
| New | +$27.1M | 0.25% | 50 |
|
|
2018
Q3 | – | Sell |
-17,053
| Closed | -$2.12M | – | 507 |
|
|
2018
Q2 | $2.12M | Buy |
+17,053
| New | +$2.12M | 0.02% | 194 |
|
|
2018
Q1 | – | Sell |
-65,212
| Closed | -$7.8M | – | 499 |
|
|
2017
Q4 | $7.8M | Sell |
65,212
-52,206
| -44% | -$6.24M | 0.06% | 59 |
|
|
2017
Q3 | $16.5M | Buy |
117,418
+111,020
| +1,735% | +$15.6M | 0.11% | 38 |
|
|
2017
Q2 | $778K | Sell |
6,398
-6,972
| -52% | -$848K | 0.01% | 226 |
|
|
2017
Q1 | $1.62M | Buy |
+13,370
| New | +$1.62M | 0.02% | 163 |
|
|
2015
Q2 | – | Sell |
-29,099
| Closed | -$5.04M | – | 413 |
|
|
2015
Q1 | $5.04M | Buy |
29,099
+10,586
| +57% | +$1.83M | 0.04% | 126 |
|
|
2014
Q4 | $3.43M | Buy |
+18,513
| New | +$3.43M | 0.03% | 153 |
|
|
2014
Q3 | – | Sell |
-26,332
| Closed | -$4.11M | – | 433 |
|
|
2014
Q2 | $4.11M | Sell |
26,332
-24,039
| -48% | -$3.76M | 0.03% | 125 |
|
|
2014
Q1 | $7.66M | Buy |
+50,371
| New | +$7.66M | 0.06% | 65 |
|